Save 22% on attending (Only $389 + on-demand included). Offer expires in:
Day(s)
:
Hour(s)
:
Minute(s)
:
Second(s)
The drug development model is in need of a drastic shakeup and COVID-19 has only accelerated this. Now more than ever is there a need to initiate innovative formulation, delivery and development approaches in order to improve bioavailability and therapeutic performance. We’re here to help you improve drug performance, bioavailability, and patient adherence.
This intensive 2-Day program will showcase industry’s latest formulation and delivery technologies for enhancing solubility and maximizing bioavailability. 2021’s Summit will share cutting edge research on the development, characterization and manufacture of formulations that span multiple modalities.
Sign-up for October’s 2021 Global Drug Bioavailability Enhancement Virtual Summit and walk away with over 2 years of new drug formulation and bioavailability enhancement approaches strategies in just 2 short days! Additionally, expand your network further with 100’s of leading drug product development professionals around the world.
Can’t make it this October? Don’t worry, the full virtual event is recorded and available On-Demand also so you and your team won’t miss a thing.
Want to attend but need help to convince your boss?
Let us help by generating you a custom message for you to send to your boss. Email it, talk them through it in person, tweet it to them 280 characters at a time: up to you.
- Precision medicine & healthcare delivery
- Rationale formulation design for poorly soluble compounds
- In-vivo – in-vitro correlation
- Solution behavior of amorphous solid dispersions
- Nanosuspension for improving the bioavailability
- Early formulation screening in drug discovery
- 3D printing for biopharmaceuticals
- Enhancing patient adherence via drug delivery
- Innovative strategies around drug / device combinations
2021’s Speakers Include:
Dedong Wu, PhD
Senior Scientist, Solid State
AstraZeneca
Manish Gupta, PhD
Senior Director, Pharmaceutical Development - Sterile
GlaxoSmithKline
Arijit Chakravarty, PhD
Chief Executive Officer
Fractal Therapeutics
Rick Panicucci, PhD
Senior Vice President, CMC
QED Therapeutics
Susan Rosenbaum
Founder, Chairman & Chief Executive Officer
Lauren Sciences
Eric Munson, PhD
Patrick DeLuca Endowed Professor in Pharmaceutical Technology, Department of Pharmaceutical Sciences
Purdue University
Di Wu, PhD
Senior Scientist, Formulation Development
Merck & Co.
Stephen Stern, PhD
Director of Research and Development, Head of the Pharmacology and Toxicology Section
Nanotechnology Characterization Laboratory
Dabing Chen, PhD
Senior Principal Scientist
Boehringer Ingelheim
Xin Liu, PhD
Associate Director of Pharmaceutical Product Development
Triasek
Stephen Tindal, PhD
Director, Science & Technology
Catalent Pharma Solutions
Melanie Marota, PhD
Associate Principal Scientist, Pharmaceutical Sciences
Merck & Co.
30+
100's
of Senior Participants
8+
Networking Segments
16
2021 Sponsors & Exhibitors
Attendance Pricing
Super Early-Bird
Register Before Sept 17, 2021
Virtual Summit
$309
Early-Bird Pricing
Register Before Oct 1, 2021
Virtual Summit
$389
Standard Pricing
Register October 2, 2021 Onwards
Virtual Summit
$499
FREE WEBINAR: An Integrated Approach to Spray Drying: From Development to Manufacturing
Matt Ling, PhD
Director of Scientific Services
Catalent Pharma Solutions
During this session, Matt Ling from Catalent provides an overview of the spray drying process and discusses the formulation development roadmap, which includes solvent screening, polymer selection, determination of initial API loading, and characterization of the spray dried product. The talk will also briefly touch on Catalent’s integrated spray drying capabilities to support early stage development through to commercial scale dose manufacturing. Learning objectives:
1. Find out when is spray drying is considered the right technology for bioavailability enhancement
2. Key formulation considerations for spray drying
3. Learn how the process parameters affect product quality.
Featured Posts
Structure-guided Discovery of Solid Forms to Drive Oral Bioavailability of Protease Inhibitors
Historically, oral administration has been considered the easiest and most convenient method of drug delivery, as it requires minimal expertise and invasiveness. Although oral delivery works fairly effectively for small-molecule drug products, oral delivery of...
Prodrug Approach for Improving Bioavailability
A prodrug is a medication or compound that metabolizes into a pharmacologically active drug after administration, offering opportunities to optimize the pharmaceutical property to improve bioavailability. Approximately 10% of all marketed drugs worldwide can be...
Applying Nanoparticle Delivery Approaches for Drug Development
Nanomedicines leading the way Nanotechnology offers multiple benefits in treating chronic diseases by site-specific, and target-oriented delivery of medicines. Nano-delivery systems utilized in drug development are very much still relatively new commercial approach....
Want to attend but need help to convince your boss?
Let us help by generating you a custom message for you to send to your boss. Email it, talk them through it in person, tweet it to them 280 characters at a time: up to you.